IBM Common StockIBMDON'T BUYJan 14, 2016Stock price when the opinion was issued
As of Jul 31, 2026. Market Open.
We had these stocks that were growing off of AI, and they've been delivering spectacular growth. But they've also had spectacular increases in share prices, which becomes a potential source of volatility.
The question is whether valuations are too high given projected growth? As we've seen here, some of the price adjustments can be pretty abrupt.
Growing from multiple angles, yet valuation still reasonable. Stable and embedded business complemented by new growth drivers. Consulting business helps companies implement AI, and that's where the real spending is. Strong in hybrid cloud, managing data across environments. Quantum computing already being used with potential for energy, healthcare, manufacturing.
Drop in February due to sector rotation and profit taking. Trades ~19x PE, attractive. Sees 30% upside from here to ~$317. Yield is 2.85%.
Hold on to it. At 4-5% growth, in the ballpark of the top players. He doesn't know its exposure to robotics. Street's pretty positive on it, about 20% upside. At 20x PE, not an aggressive valuation. Margins expected to stay healthy -- 60% gross margins, net income margins of close to 20%.
(Analysts’ price target is $314.00)
A very good example of old technology versus new technology. It appears cheap from a fundamental level, trading at 9X on a forward basis and 8X on a trailing basis. The growth rate is the issue. There is a lack of confidence that this company can transition from more of its legacy technologies such as software, etc., to more of the analytics, the cloud, mobile and security.